Sequencing BCMA Myeloma Therapies

Name: Sequencing BCMA Myeloma Therapies
Start: 2023-04-11T13:00:00-04:00
End: 2023-04-11T14:00:00-04:00

Sequencing BCMA Myeloma Therapies

Apr 11, 2023 / 01:00PM - 02:00PM EDT

Event Description

Let's learn together what we know about sequencing BCMA therapies, and what there's left to learn. As more immunotherapies targeting BCMA on cancerous myeloma plasma cells continue to be develop, there is question about which combination of these treatments is most efficacious, and what precautions need to be taken when using such similar targeted therapies. Join Dr. Josh Richter, a myeloma specialist, as he shares information regarding this topic.

Schedule & Agenda

Introductions

1:00 PM

Audrey Burton-Bethke

Audrey introduces the agenda of the event and featured speaker Dr. Joshua Richter.

1 :00 PM

Audrey Burton-Bethke

Introductions

Audrey introduces the agenda of the event and featured speaker Dr. Joshua Richter.

Presentation

1:05 PM

Joshua Richter, MD

Dr. Joshua Richter shares about sequencing BCMA therapies.

1 :05 PM

Joshua Richter, MD

Presentation

Dr. Joshua Richter shares about sequencing BCMA therapies.

Questions and Answers

1:35 PM

Audience

Type your questions in the chat and we will answer them!

1 :35 PM

Audience

Questions and Answers

Type your questions in the chat and we will answer them!

Speakers & Moderators

Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.

Read Bio

Joshua Richter, MD

Joshua Richter, MD, is Associate Professor of Medicine in The Tisch Cancer Institute, Division of Hematology and Medical Oncology. He is the director of Multiple Myeloma at the Blavatnik Family- Chelsea Medical Center at Mount Sinai. Dr. Richter treats patients with plasma cell dyscrasias, including multiple myeloma and related diseases such as AL amyloidosis, plasma cell leukemia, and Waldenstrom’s Macroglobulinemia. Dr. Richter has extensive experience with clinical trials focused on novel therapies, including antibody therapy and immunotherapy for a precision medicine approach. He has published extensively on these topics and has been invited to speak regionally, nationally, and also internationally. He has been published in journals such as the New England Journal of Medicine, Blood, and the Journal of Clinical Oncology.

Read Bio